Form 4 holding
President, Worldwide R&D
BIOMARIN PHARMACEUTICAL INC
- Security class
- Common Stock
- Shares / value
- 185,074
- Estimated value
- $15,712,783
- Report date
- 13 Sep 2024
- Price
- $84.90
- Ownership
- Direct
Henry J. Fuchs - President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC
Issuer-level insider activity
- Role
- President, Worldwide R&D
- Issuer ticker
- BMRN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Henry J. Fuchs since 03 Aug 2025
Reported holdings for Henry J. Fuchs in BIOMARIN PHARMACEUTICAL INC
Form 4 holding
President, Worldwide R&D
BIOMARIN PHARMACEUTICAL INC
- Security class
- Stock Option (Right to Buy Common Stock)
- Shares / value
- 40,860
- Estimated value
- Report date
- 15 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Henry J. Fuchs in BIOMARIN PHARMACEUTICAL INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.